Failure of thrombolytic therapy to improve long-term vascular patency

Purpose: Few data are available on long-term follow-up of arterial segments subjected to thrombolysis. We reviewed all cases of vascular occlusion treated with urokinase to identify early success and determine the influence of postlysis intervention and the nature of the thrombosed segment (i.e., ar...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of vascular surgery 1994-02, Vol.19 (2), p.289-297
Hauptverfasser: Faggioli, Gian Luca, Peer, Richard M., Pedrini, Luciano, Di Paola, Marco Donato, Upson, James A., D'Addato, Massimo, Ricotta, John J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 297
container_issue 2
container_start_page 289
container_title Journal of vascular surgery
container_volume 19
creator Faggioli, Gian Luca
Peer, Richard M.
Pedrini, Luciano
Di Paola, Marco Donato
Upson, James A.
D'Addato, Massimo
Ricotta, John J.
description Purpose: Few data are available on long-term follow-up of arterial segments subjected to thrombolysis. We reviewed all cases of vascular occlusion treated with urokinase to identify early success and determine the influence of postlysis intervention and the nature of the thrombosed segment (i.e., artery vs graft) on long-term patency. Methods: Data on 134 cases (58 arteries, 76 grafts) treated with high-dose urokinase infusion in the lower limbs over a 7-year period were analyzed. Limbs were divided into five groups on the basis of therapy after lytic infusion to determine long-term efficacy: group I, success with no additional therapy; group II, percutaneous angioplasty alone; group III, limited surgical procedure (operative angioplasty, jump graft); group IV, extensive procedure (new bypass); and group V, revascularization after lytic failure. Long-term results were assessed by life-table analysis and groups compared by log-rank test (Mantel-Haenszel). Results: Initial patency was established in 87 (64.9%) of 134 cases with 5 deaths (3.7%), 11 amputations (8.2%), and 16 complications (11.9%). Follow-up was available in 68.6% of cases for a mean of 10.9 months. No difference was seen between grafts and native arteries. Patency was analyzed at 6, 12, 18, and 24 months. The 24-month patency rate after lysis alone (group I - 25.9%) was inferior ( p < 0.05) to results after lysis and any subsequent intervention (groups II, III, and IV). The type of intervention did not influence subsequent patency. 24–month patency of procedures performed after failed thrombolysis (group V, 41.4%) was not different from those after successful lysis (groups I to IV). 24–month patency in groups II and III (minor interventions, 62.9%) was not significantly different from that of groups IV and V (major interventions, 53.2%) ( p > 0.25). Conclusions: Operative intervention is required to produce long-term arterial patency, even after successful thrombolysis. No statistically significant benefit of thrombolysis on vascular patency was seen in our series. (J V ASC S URG 1994;19:289-97.)
doi_str_mv 10.1016/S0741-5214(94)70104-0
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_76373356</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0741521494701040</els_id><sourcerecordid>76373356</sourcerecordid><originalsourceid>FETCH-LOGICAL-c407t-5f7b44a85bc6322b26173d849d406ff88e93d168ea1ba70d3fb85decbb5627093</originalsourceid><addsrcrecordid>eNqFkMtOwzAQRS0EKqXwCZWyQrAIjBPHdlYIVS0gVWIBrC3bmYBRUhc7qdS_J32ILavR6N47j0PIlMIdBcrv30AwmhYZZTcluxVAgaVwQsYUSpFyCeUpGf9ZzslFjN8AlBZSjMhIUspoCWMyX2jX9AETXyfdV_Ct8c22c3ZoMOj1Nul84tp18BtMGr_6TDsMbbLR0faNDslad7iy20tyVusm4tWxTsjHYv4-e06Xr08vs8dlahmILi1qYRjTsjCW51lmMk5FXklWVgx4XUuJZV5RLlFTowVUeW1kUaE1puCZgDKfkOvD3OGgnx5jp1oXLTaNXqHvoxI8F3le8MFYHIw2-BgD1modXKvDVlFQO3xqj0_t2KiSqT0-BUNuelzQmxarv9SR16A_HHQcvtw4DCpaNxDAygW0naq8-2fDL9NRf2k</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>76373356</pqid></control><display><type>article</type><title>Failure of thrombolytic therapy to improve long-term vascular patency</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Faggioli, Gian Luca ; Peer, Richard M. ; Pedrini, Luciano ; Di Paola, Marco Donato ; Upson, James A. ; D'Addato, Massimo ; Ricotta, John J.</creator><creatorcontrib>Faggioli, Gian Luca ; Peer, Richard M. ; Pedrini, Luciano ; Di Paola, Marco Donato ; Upson, James A. ; D'Addato, Massimo ; Ricotta, John J.</creatorcontrib><description>Purpose: Few data are available on long-term follow-up of arterial segments subjected to thrombolysis. We reviewed all cases of vascular occlusion treated with urokinase to identify early success and determine the influence of postlysis intervention and the nature of the thrombosed segment (i.e., artery vs graft) on long-term patency. Methods: Data on 134 cases (58 arteries, 76 grafts) treated with high-dose urokinase infusion in the lower limbs over a 7-year period were analyzed. Limbs were divided into five groups on the basis of therapy after lytic infusion to determine long-term efficacy: group I, success with no additional therapy; group II, percutaneous angioplasty alone; group III, limited surgical procedure (operative angioplasty, jump graft); group IV, extensive procedure (new bypass); and group V, revascularization after lytic failure. Long-term results were assessed by life-table analysis and groups compared by log-rank test (Mantel-Haenszel). Results: Initial patency was established in 87 (64.9%) of 134 cases with 5 deaths (3.7%), 11 amputations (8.2%), and 16 complications (11.9%). Follow-up was available in 68.6% of cases for a mean of 10.9 months. No difference was seen between grafts and native arteries. Patency was analyzed at 6, 12, 18, and 24 months. The 24-month patency rate after lysis alone (group I - 25.9%) was inferior ( p &lt; 0.05) to results after lysis and any subsequent intervention (groups II, III, and IV). The type of intervention did not influence subsequent patency. 24–month patency of procedures performed after failed thrombolysis (group V, 41.4%) was not different from those after successful lysis (groups I to IV). 24–month patency in groups II and III (minor interventions, 62.9%) was not significantly different from that of groups IV and V (major interventions, 53.2%) ( p &gt; 0.25). Conclusions: Operative intervention is required to produce long-term arterial patency, even after successful thrombolysis. No statistically significant benefit of thrombolysis on vascular patency was seen in our series. (J V ASC S URG 1994;19:289-97.)</description><identifier>ISSN: 0741-5214</identifier><identifier>EISSN: 1097-6809</identifier><identifier>DOI: 10.1016/S0741-5214(94)70104-0</identifier><identifier>PMID: 8114190</identifier><language>eng</language><publisher>United States: Mosby, Inc</publisher><subject>Angioplasty ; Combined Modality Therapy ; Follow-Up Studies ; Graft Occlusion, Vascular - mortality ; Graft Occlusion, Vascular - therapy ; Humans ; Infusions, Intra-Arterial ; Ischemia - mortality ; Ischemia - therapy ; Leg - blood supply ; Life Tables ; Thrombolytic Therapy - methods ; Treatment Failure ; Urokinase-Type Plasminogen Activator - pharmacology ; Urokinase-Type Plasminogen Activator - therapeutic use ; Vascular Patency - drug effects</subject><ispartof>Journal of vascular surgery, 1994-02, Vol.19 (2), p.289-297</ispartof><rights>1994 Society for Vascular Surgery and International Society for Cardiovascular Surgery, North American Chapter</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c407t-5f7b44a85bc6322b26173d849d406ff88e93d168ea1ba70d3fb85decbb5627093</citedby><cites>FETCH-LOGICAL-c407t-5f7b44a85bc6322b26173d849d406ff88e93d168ea1ba70d3fb85decbb5627093</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0741-5214(94)70104-0$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8114190$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Faggioli, Gian Luca</creatorcontrib><creatorcontrib>Peer, Richard M.</creatorcontrib><creatorcontrib>Pedrini, Luciano</creatorcontrib><creatorcontrib>Di Paola, Marco Donato</creatorcontrib><creatorcontrib>Upson, James A.</creatorcontrib><creatorcontrib>D'Addato, Massimo</creatorcontrib><creatorcontrib>Ricotta, John J.</creatorcontrib><title>Failure of thrombolytic therapy to improve long-term vascular patency</title><title>Journal of vascular surgery</title><addtitle>J Vasc Surg</addtitle><description>Purpose: Few data are available on long-term follow-up of arterial segments subjected to thrombolysis. We reviewed all cases of vascular occlusion treated with urokinase to identify early success and determine the influence of postlysis intervention and the nature of the thrombosed segment (i.e., artery vs graft) on long-term patency. Methods: Data on 134 cases (58 arteries, 76 grafts) treated with high-dose urokinase infusion in the lower limbs over a 7-year period were analyzed. Limbs were divided into five groups on the basis of therapy after lytic infusion to determine long-term efficacy: group I, success with no additional therapy; group II, percutaneous angioplasty alone; group III, limited surgical procedure (operative angioplasty, jump graft); group IV, extensive procedure (new bypass); and group V, revascularization after lytic failure. Long-term results were assessed by life-table analysis and groups compared by log-rank test (Mantel-Haenszel). Results: Initial patency was established in 87 (64.9%) of 134 cases with 5 deaths (3.7%), 11 amputations (8.2%), and 16 complications (11.9%). Follow-up was available in 68.6% of cases for a mean of 10.9 months. No difference was seen between grafts and native arteries. Patency was analyzed at 6, 12, 18, and 24 months. The 24-month patency rate after lysis alone (group I - 25.9%) was inferior ( p &lt; 0.05) to results after lysis and any subsequent intervention (groups II, III, and IV). The type of intervention did not influence subsequent patency. 24–month patency of procedures performed after failed thrombolysis (group V, 41.4%) was not different from those after successful lysis (groups I to IV). 24–month patency in groups II and III (minor interventions, 62.9%) was not significantly different from that of groups IV and V (major interventions, 53.2%) ( p &gt; 0.25). Conclusions: Operative intervention is required to produce long-term arterial patency, even after successful thrombolysis. No statistically significant benefit of thrombolysis on vascular patency was seen in our series. (J V ASC S URG 1994;19:289-97.)</description><subject>Angioplasty</subject><subject>Combined Modality Therapy</subject><subject>Follow-Up Studies</subject><subject>Graft Occlusion, Vascular - mortality</subject><subject>Graft Occlusion, Vascular - therapy</subject><subject>Humans</subject><subject>Infusions, Intra-Arterial</subject><subject>Ischemia - mortality</subject><subject>Ischemia - therapy</subject><subject>Leg - blood supply</subject><subject>Life Tables</subject><subject>Thrombolytic Therapy - methods</subject><subject>Treatment Failure</subject><subject>Urokinase-Type Plasminogen Activator - pharmacology</subject><subject>Urokinase-Type Plasminogen Activator - therapeutic use</subject><subject>Vascular Patency - drug effects</subject><issn>0741-5214</issn><issn>1097-6809</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtOwzAQRS0EKqXwCZWyQrAIjBPHdlYIVS0gVWIBrC3bmYBRUhc7qdS_J32ILavR6N47j0PIlMIdBcrv30AwmhYZZTcluxVAgaVwQsYUSpFyCeUpGf9ZzslFjN8AlBZSjMhIUspoCWMyX2jX9AETXyfdV_Ct8c22c3ZoMOj1Nul84tp18BtMGr_6TDsMbbLR0faNDslad7iy20tyVusm4tWxTsjHYv4-e06Xr08vs8dlahmILi1qYRjTsjCW51lmMk5FXklWVgx4XUuJZV5RLlFTowVUeW1kUaE1puCZgDKfkOvD3OGgnx5jp1oXLTaNXqHvoxI8F3le8MFYHIw2-BgD1modXKvDVlFQO3xqj0_t2KiSqT0-BUNuelzQmxarv9SR16A_HHQcvtw4DCpaNxDAygW0naq8-2fDL9NRf2k</recordid><startdate>19940201</startdate><enddate>19940201</enddate><creator>Faggioli, Gian Luca</creator><creator>Peer, Richard M.</creator><creator>Pedrini, Luciano</creator><creator>Di Paola, Marco Donato</creator><creator>Upson, James A.</creator><creator>D'Addato, Massimo</creator><creator>Ricotta, John J.</creator><general>Mosby, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19940201</creationdate><title>Failure of thrombolytic therapy to improve long-term vascular patency</title><author>Faggioli, Gian Luca ; Peer, Richard M. ; Pedrini, Luciano ; Di Paola, Marco Donato ; Upson, James A. ; D'Addato, Massimo ; Ricotta, John J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c407t-5f7b44a85bc6322b26173d849d406ff88e93d168ea1ba70d3fb85decbb5627093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Angioplasty</topic><topic>Combined Modality Therapy</topic><topic>Follow-Up Studies</topic><topic>Graft Occlusion, Vascular - mortality</topic><topic>Graft Occlusion, Vascular - therapy</topic><topic>Humans</topic><topic>Infusions, Intra-Arterial</topic><topic>Ischemia - mortality</topic><topic>Ischemia - therapy</topic><topic>Leg - blood supply</topic><topic>Life Tables</topic><topic>Thrombolytic Therapy - methods</topic><topic>Treatment Failure</topic><topic>Urokinase-Type Plasminogen Activator - pharmacology</topic><topic>Urokinase-Type Plasminogen Activator - therapeutic use</topic><topic>Vascular Patency - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Faggioli, Gian Luca</creatorcontrib><creatorcontrib>Peer, Richard M.</creatorcontrib><creatorcontrib>Pedrini, Luciano</creatorcontrib><creatorcontrib>Di Paola, Marco Donato</creatorcontrib><creatorcontrib>Upson, James A.</creatorcontrib><creatorcontrib>D'Addato, Massimo</creatorcontrib><creatorcontrib>Ricotta, John J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of vascular surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Faggioli, Gian Luca</au><au>Peer, Richard M.</au><au>Pedrini, Luciano</au><au>Di Paola, Marco Donato</au><au>Upson, James A.</au><au>D'Addato, Massimo</au><au>Ricotta, John J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Failure of thrombolytic therapy to improve long-term vascular patency</atitle><jtitle>Journal of vascular surgery</jtitle><addtitle>J Vasc Surg</addtitle><date>1994-02-01</date><risdate>1994</risdate><volume>19</volume><issue>2</issue><spage>289</spage><epage>297</epage><pages>289-297</pages><issn>0741-5214</issn><eissn>1097-6809</eissn><abstract>Purpose: Few data are available on long-term follow-up of arterial segments subjected to thrombolysis. We reviewed all cases of vascular occlusion treated with urokinase to identify early success and determine the influence of postlysis intervention and the nature of the thrombosed segment (i.e., artery vs graft) on long-term patency. Methods: Data on 134 cases (58 arteries, 76 grafts) treated with high-dose urokinase infusion in the lower limbs over a 7-year period were analyzed. Limbs were divided into five groups on the basis of therapy after lytic infusion to determine long-term efficacy: group I, success with no additional therapy; group II, percutaneous angioplasty alone; group III, limited surgical procedure (operative angioplasty, jump graft); group IV, extensive procedure (new bypass); and group V, revascularization after lytic failure. Long-term results were assessed by life-table analysis and groups compared by log-rank test (Mantel-Haenszel). Results: Initial patency was established in 87 (64.9%) of 134 cases with 5 deaths (3.7%), 11 amputations (8.2%), and 16 complications (11.9%). Follow-up was available in 68.6% of cases for a mean of 10.9 months. No difference was seen between grafts and native arteries. Patency was analyzed at 6, 12, 18, and 24 months. The 24-month patency rate after lysis alone (group I - 25.9%) was inferior ( p &lt; 0.05) to results after lysis and any subsequent intervention (groups II, III, and IV). The type of intervention did not influence subsequent patency. 24–month patency of procedures performed after failed thrombolysis (group V, 41.4%) was not different from those after successful lysis (groups I to IV). 24–month patency in groups II and III (minor interventions, 62.9%) was not significantly different from that of groups IV and V (major interventions, 53.2%) ( p &gt; 0.25). Conclusions: Operative intervention is required to produce long-term arterial patency, even after successful thrombolysis. No statistically significant benefit of thrombolysis on vascular patency was seen in our series. (J V ASC S URG 1994;19:289-97.)</abstract><cop>United States</cop><pub>Mosby, Inc</pub><pmid>8114190</pmid><doi>10.1016/S0741-5214(94)70104-0</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0741-5214
ispartof Journal of vascular surgery, 1994-02, Vol.19 (2), p.289-297
issn 0741-5214
1097-6809
language eng
recordid cdi_proquest_miscellaneous_76373356
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; ScienceDirect Journals (5 years ago - present)
subjects Angioplasty
Combined Modality Therapy
Follow-Up Studies
Graft Occlusion, Vascular - mortality
Graft Occlusion, Vascular - therapy
Humans
Infusions, Intra-Arterial
Ischemia - mortality
Ischemia - therapy
Leg - blood supply
Life Tables
Thrombolytic Therapy - methods
Treatment Failure
Urokinase-Type Plasminogen Activator - pharmacology
Urokinase-Type Plasminogen Activator - therapeutic use
Vascular Patency - drug effects
title Failure of thrombolytic therapy to improve long-term vascular patency
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T19%3A03%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Failure%20of%20thrombolytic%20therapy%20to%20improve%20long-term%20vascular%20patency&rft.jtitle=Journal%20of%20vascular%20surgery&rft.au=Faggioli,%20Gian%20Luca&rft.date=1994-02-01&rft.volume=19&rft.issue=2&rft.spage=289&rft.epage=297&rft.pages=289-297&rft.issn=0741-5214&rft.eissn=1097-6809&rft_id=info:doi/10.1016/S0741-5214(94)70104-0&rft_dat=%3Cproquest_cross%3E76373356%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=76373356&rft_id=info:pmid/8114190&rft_els_id=S0741521494701040&rfr_iscdi=true